ReviewFrontiers in cellular neuroscience2026
Primary cilia as a molecular convergence hub linking neurodevelopment and autism spectrum disorder.
Review in Frontiers in cellular neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The primary cilium, a highly conserved microtubule-based organelle, orchestrates a broad repertoire of signal transduction cascades required for embryonic development, tissue homeostasis and cellular communication. Disruption of ciliary structure or function results in a heterogeneous group of multisystem disorders known as ciliopathies. Emerging genomic and transcriptomic evidence indicates that perturbation of ciliary architecture or signaling may also contribute to neurodevelopmental conditions and specifically to autism spectrum disorder (ASD). Genes linked to ASD show a wide range of genetic and phenotypic characteristics: spanning from syndromic neurodevelopmental disorders with overlapping ciliopathy features to idiopathic ASD. Yet the mechanistic contribution of ASD risk genes to ciliary biology remains insufficiently characterized. This study aims to explore the molecular convergence between ciliopathies and ASD by systematically interrogating ciliary gene datasets (CiliaCarta and SysCilia GSv2) in cross-comparison to ASD-associated gene repositories (SFARI Gene). This integrative analysis identifies 105 high-confidence shared genes, which segregate into four mechanistic modules: (i) structural determinants of cilium assembly and maintenance, (ii) components of cilium-dependent signaling pathways, (iii) regulators of cilium-associated gene expression and (iv) cilium associated pathways. We propose that ciliary dysfunction constitutes a convergent mechanism, perturbing neurodevelopmental signaling, neuronal polarity and synaptic maturation in a subset of ASD cases. Clarifying the role of the genes shared between ciliogenesis and neurodevelopmental signaling will refine genotype-to-phenotype correlations, expand the spectrum of cilia-associated neurodevelopmental disorders and potentially uncover therapeutically actionable hubs within cilium-dependent signaling circuitry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.